CCNI and cervical cancer: A notable example is found in cervical cancer, where resistance to the chemotherapeutic agent cisplatin is driven by the upregulation of Cyclin I. In this context, the Cyclin I-Cdk5 complex functions as a critical anti-apoptotic factor, protecting cancer cells from drug-induced cell death [113].